Galactomannan antigenemia for the diagnosis of invasive aspergillosis in neutropenic patients with hematological disorders

Journal of the Medical Association of Thailand

Volumn 89, Issue 11, 2006, Pages 1851-1858

  Suankratay, Chusana ^a   Kanitcharaskul, Phichai ^a   Arunyingmongkol, Kesinee ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Febrile neutropenia; Galactomannan antigen; Galactomannan enzyme immunosorbent assay; Invasive aspergillosis; Invasive fungal infection

Indexed keywords

AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; GALACTOMANNAN; ITRACONAZOLE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; ASPERGILLOSIS; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FEVER; HEMATOLOGIC DISEASE; HOSPITALIZATION; HUMAN; MALE; NEUTROPENIA; SENSITIVITY AND SPECIFICITY; THAILAND; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANTIGENS, FUNGAL; ASPERGILLOSIS; BIOLOGICAL MARKERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMATOLOGIC DISEASES; HUMANS; IMMUNOCOMPROMISED HOST; MALE; MANNANS; MIDDLE AGED; NEUTROPENIA; OPPORTUNISTIC INFECTIONS; PROSPECTIVE STUDIES; REAGENT KITS, DIAGNOSTIC; RISK; SENSITIVITY AND SPECIFICITY;

EID: 33845474522     PISSN: 01252208     EISSN: 01252208     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Denning DW, Stevens DA. Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases. Rev Infect Dis 1990; 12: 1147-201.
2. Giamarellou H, Antoniadou A. Infectious complications of febrile leukopenia. Infect Dis Clin North Am 2001; 15: 457-82.
3. Bodey GP, Vartivarian S. Aspergillosis. Eur J Clin Microbiol Infect Dis 1989; 8: 413-37.
4. Rinaldi MG. Problems in the diagnosis of invasive fungal diseases. Rev Infect Dis 1991; 13: 493-5.
5. Martino R, Subira M. Invasive fungal infections in hematology: new trends. Ann Hematol 2002; 81: 233-43.
6. Aisner J, Wiernik PH, Schimpff SC. Treatment of invasive aspergillosis: relation of early diagnosis and treatment to response. Ann Intern Med 1977; 86: 539-43.
7. Groll AH, Shah PM, Mentzel C, Schneider M, Just-Nuebling G, Huebner K. Trends in the postmortem epidemiology of invasive fungal infections at a university hospital. J Infect 1996; 33: 23-32.
8. Denning DW. Early diagnosis of invasive aspergillosis. Lancet 2000; 355: 423-4.
9. Yeo SF, Wong B. Current status of nonculture methods for diagnosis of invasive fungal infections. Clin Microbiol Rev 2002; 15: 465-84.
10. Mennink-Kersten MA, Donnelly JP, Verweij PE. Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis. Lancet Infect Dis 2004; 4: 349-57.
11. Stynen D, Goris A, Sarfati J, Latge JP. A new sensitive sandwich enzyme-linked immunosorbent assay to detect galactofuran in patients with invasive aspergillosis. J Clin Microbiol 1995; 33: 497-500.
12. Denning DW. Invasive aspergillosis. Clin Infect Dis 1998; 26: 781-803.
13. Ascioglu S, Rex JH, de Pauw B, Bennett JE, Bille J, Crokaert F, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002; 34: 7-14.
14. Maertens J, Verhaegen J, Lagrou K, Van Eldere J, Boogaerts M. Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation. Blood 2001; 97: 1604-10.
15. Horvath JA, Dummer S. The use of respiratory-tract cultures in the diagnosis of invasive pulmonary aspergillosis. Am J Med 1996; 100: 171-8.
16. Stynen D, Sarfati J, Goris A, Prevost MC, Lesourd M, Kamphuis H, et al. Rat monoclonal antibodies against Aspergillus galactomannan. Infect Immun 1992; 60: 2237-45.
17. Marr KA, Balajee SA, McLaughlin L, Tabouret M, Bentsen C, Walsh TJ. Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: variables that affect performance. J Infect Dis 2004; 190: 641-9.
18. Maertens J, Van Eldere J, Verhaegen J, Verbeken E, Verschakelen J, Boogaerts M. Use of circulating galactomannan screening for early diagnosis of invasive aspergillosis in allogeneic stem cell transplant recipients. J Infect Dis 2002; 186: 1297-306.
19. Yoo JH, Choi JH, Choi SM, Lee DG, Shin WS, Min WS, et al. Application of nucleic acid sequence-based amplification for diagnosis of and monitoring the clinical course of invasive aspergillosis in patients with hematologic diseases. Clin Infect Dis 2005; 40: 392-8.
20. Bretagne S, Marmorat-Khuong A, Kuentz M, Latge JP, Bart-Delabesse E, Cordonnier C. Serum aspergillus galactomannan antigen testing by sandwich ELISA: practical use in neutropenic patients. J Infect 1997; 35: 7-15.
21. Sulahian A, Touratier S, Ribaud P. False positive test for aspergillus antigenemia related to concomitant administration of piperacillin and tazobactam. N Engl J Med 2003; 349: 2366-7.